L. M. Ossege

Changes of the MS functional composite and EDSS during and after treatment of relapses with methylprednisolone in patients with multiple sclerosis

T. Patzold, M. Schwengelbeck, L. M. Ossege et al. · Acta Neurologica Scandinavica · 2002 · 66 citations · Full text

Differential release of β-chemokines in serum and CSF of patients with relapsing-remitting multiple sclerosis

E. Sindern, Y. Niederkinkhaus, Markus Henschel et al. · Acta Neurologica Scandinavica · 2001 · 53 citations

Expression of chemokine receptor CXCR3 on cerebrospinal fluid T-cells is related to active MRI lesion appearance in patients with relapsing–remitting multiple sclerosis

E. Sindern, T. Patzold, L. M. Ossege et al. · Journal of Neuroimmunology · 2002 · 42 citations

Chemokine Receptor Cxcr3, Neurological Disorder, Medicine +8

Potential role of transforming growth factor-?1 in terminating the immune response in patients with Guillain-Barr� syndrome

E. Sindern, Klaus Schweppe, L. M. Ossege et al. · Journal of Neurology · 1996 · 29 citations

Immunogenetics, Allergy, Autoimmune Disease +11

Immunomodulatory effects of interferon-β-1b in vivo: induction of the expression of transforming growth factor-β1 and its receptor type II

L. M. Ossege, E. Sindern, T. Patzold et al. · Journal of Neuroimmunology · 1998 · 27 citations

Inflammation, Cytokine, Molecular Immunology +14